Scientists Uncover Missing Matter in Universe, Solve Cosmic Puzzle

For decades, scientists have been puzzled by the elusive nature of ordinary matter, which forms the fabric of stars, planets, and life itself. Recent breakthroughs, however, have shed light on this cosmic puzzle thanks to the discovery and analysis of fast radio bursts (FRBs). These fleeting yet powerful radio waves have become the key to … Read more

Pacers’ Unlikely Cinderella Run Ends with NBA Finals Showdown

The Indiana Pacers, underdogs in every sense, are one win away from claiming their first NBA championship in 25 years. Led by stars Pascal Siakam and Tyrese Haliburton, the team has defied expectations to reach the finals. Aaron Nesmith, who played through an ankle sprain, was the last to celebrate with his teammates as they … Read more

Tigers Wait Out Rain Delay in Tampa Bay

The Detroit Tigers’ series against the Tampa Bay Rays has been delayed due to rain, with the first game now set to start at 7:55 p.m. after an initial delay of 40 minutes. This is not the Tigers’ first weather-related issue; they previously postponed a game against the Pittsburgh Pirates on Wednesday and had their … Read more

Federal Retirement COLA Rises to 2 Percent

The Consumer Price Index (CPI) inflation index has reached 2 percent, setting the stage for federal retirees under the Federal Employees Retirement System (FERS) to receive their annual cost-of-living adjustment (COLA). This increase marks a 0.2 percentage point rise from May’s inflation rate and follows only one month of negative inflation since November’s 0.1 percentage … Read more

Syria Church Bombing Leaves At Least 20 Dead

A suicide bomber attacked a church in Damascus on Sunday, killing at least 20 people and wounding dozens more. The blast occurred during mass inside the Mar Elias Church on the outskirts of the city. According to the Syrian Ministry of Health and security officials, the attacker entered the church wearing an explosives vest and … Read more

Novo Nordisk’s CagriSema Obesity Treatment Raises Concerns on Progress

Novo Nordisk’s obesity treatment candidate CagriSema has shown mixed results in late-stage trials, sparking concerns that it may not live up to investors’ expectations. The drug was compared to Eli Lilly’s Zepbound in safety and efficacy trials. While CagriSema led to a 20% weight loss in patients over 68 weeks, similar to Zepbound, the rate … Read more